Haemonetics Stock Price on November 18, 2024

HAE Stock  USD 82.30  1.04  1.25%   
Below is the normalized historical share price chart for Haemonetics extending back to May 10, 1991. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Haemonetics stands at 82.30, as last reported on the 13th of December 2024, with the highest price reaching 83.15 and the lowest price hitting 81.30 during the day.
IPO Date
9th of May 1991
200 Day MA
82.7261
50 Day MA
80.7396
Beta
0.321
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in Haemonetics Stock, it is important to understand the factors that can impact its price. At this point, Haemonetics is very steady. Haemonetics holds Efficiency (Sharpe) Ratio of 0.0604, which attests that the entity had a 0.0604% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Haemonetics, which you can use to evaluate the volatility of the firm. Please check out Haemonetics' Risk Adjusted Performance of 0.0771, downside deviation of 1.63, and Market Risk Adjusted Performance of 0.2024 to validate if the risk estimate we provide is consistent with the expected return of 0.14%.
  
At present, Haemonetics' Other Stockholder Equity is projected to increase significantly based on the last few years of reporting. . At present, Haemonetics' Price Earnings Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price Book Value Ratio is expected to grow to 5.13, whereas Price To Operating Cash Flows Ratio is forecasted to decline to 17.52. Haemonetics Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0604

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskHAEHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 2.25
  actual daily
20
80% of assets are more volatile

Expected Return

 0.14
  actual daily
2
98% of assets have higher returns

Risk-Adjusted Return

 0.06
  actual daily
4
96% of assets perform better
Based on monthly moving average Haemonetics is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Haemonetics by adding it to a well-diversified portfolio.
Price Book
4.7626
Enterprise Value Ebitda
18.4593
Price Sales
3.0749
Shares Float
49.7 M
Wall Street Target Price
111.2727

Haemonetics Valuation on November 18, 2024

It is possible to determine the worth of Haemonetics on a given historical date. On November 18, 2024 Haemonetics was worth 89.24 at the beginning of the trading date compared to the closed value of 88.17. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Haemonetics stock. Still, in general, we apply an absolute valuation method to find Haemonetics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Haemonetics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Haemonetics' related companies.
 Open High Low Close Volume
  91.37    91.43    88.64    89.22    564,400  
11/18/2024
  89.24    89.73    88.15    88.17    553,605  
  87.37    87.48    84.76    84.83    766,810  
Backtest Haemonetics  |  Haemonetics History  |  Haemonetics Valuation   PreviousNext  
Open Value
89.24
88.17
Closing Value
95.99
Upside

Haemonetics Trading Date Momentum on November 18, 2024

On November 19 2024 Haemonetics was traded for  84.83  at the closing time. Highest Haemonetics's price during the trading hours was 87.48  and the lowest price during the day was  84.76 . The net volume was 766.8 K. The overall trading history on the 19th of November contributed to the next trading period price depreciation. The trading delta at closing time to the next next day price was 3.79% . The trading delta at closing time to current price is 0.28% .

Haemonetics Fundamentals Correlations and Trends

By evaluating Haemonetics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Haemonetics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Haemonetics financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Haemonetics Stock history

Haemonetics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Haemonetics is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Haemonetics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Haemonetics stock prices may prove useful in developing a viable investing in Haemonetics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding51.4 M42.5 M
Net Income Applicable To Common Shares132.7 M139.3 M

Haemonetics Quarterly Net Working Capital

681.96 Million

Haemonetics Stock Technical Analysis

Haemonetics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Haemonetics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Haemonetics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Haemonetics Period Price Range

Low
December 13, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Haemonetics cannot be verified against its exchange. Please verify the symbol is currently traded on New York Stock Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Haemonetics December 13, 2024 Market Strength

Market strength indicators help investors to evaluate how Haemonetics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Haemonetics shares will generate the highest return on investment. By undertsting and applying Haemonetics stock market strength indicators, traders can identify Haemonetics entry and exit signals to maximize returns

Haemonetics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Haemonetics' price direction in advance. Along with the technical and fundamental analysis of Haemonetics Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Haemonetics to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Haemonetics Stock analysis

When running Haemonetics' price analysis, check to measure Haemonetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Haemonetics is operating at the current time. Most of Haemonetics' value examination focuses on studying past and present price action to predict the probability of Haemonetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Haemonetics' price. Additionally, you may evaluate how the addition of Haemonetics to your portfolios can decrease your overall portfolio volatility.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Money Managers
Screen money managers from public funds and ETFs managed around the world
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.